AIMC Topic: Arthritis, Juvenile

Clear Filters Showing 11 to 13 of 13 articles

Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study.

Pediatric rheumatology online journal Dec 28, 2017
BACKGROUND: Juvenile idiopathic arthritis (JIA) is the most common pediatric rheumatic disease and a leading cause of childhood disability. The objective of this study was to characterize the PK, safety, and taste acceptability of tofacitinib in pati...
Humans Female Male Adolescent Child, Preschool Child Treatment Outcome Administration, Oral Taste Arthritis, Juvenile Piperidines Protein Kinase Inhibitors Pyrimidines Pyrroles
View on PubMed DOI

Advances in pharmacotherapy of juvenile idiopathic arthritis.

Expert opinion on pharmacotherapy Jun 1, 2025
INTRODUCTION: Juvenile Idiopathic Arthritis (JIA) is the most common chronic rheumatic disease in childhood. More therapeutic options are available for the treatment of JIA with more children achieving minimal active disease or inactive disease statu...
Humans Biomarkers Child Biological Products Arthritis, Juvenile Antirheumatic Agents
View on PubMed DOI

An Explainable and Conformal AI Model to Detect Temporomandibular Joint Involvement in Children Suffering from Juvenile Idiopathic Arthritis.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference Jul 1, 2024
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease during childhood and adolescence. The temporomandibular joints (TMJ) are among the most frequently affected joints in patients with JIA, and mandibular growth is especially vuln...
Humans Artificial Intelligence Algorithms Female Male Adolescent Child Temporomandibular Joint Disorders Arthritis, Juvenile Temporomandibular Joint
View on PubMed DOI
Popular Topics
Recent Journals